Yoyime's PSA & Prostate Screening in Dubai combines individual prostate cancer risk review with appropriate PSA blood testing to support informed screening, monitoring and further evaluation where needed.

A PSA test measures prostate-specific antigen in the blood. PSA is produced by prostate tissue and the result can help identify whether further prostate assessment may be appropriate.

The appropriate age depends on individual risk. Many men may begin discussing PSA screening around age 50, while earlier assessment may be appropriate for those at increased risk.

No. An elevated PSA does not automatically indicate prostate cancer. Benign prostate enlargement, inflammation, infection and other factors can also increase PSA levels.

Earlier discussion may be appropriate for men with a strong family history of prostate cancer or other recognised risk factors. Our clinician will assess individual screening needs.

PSA testing can help identify men who may benefit from further prostate evaluation before symptoms appear. It does not diagnose cancer by itself and must be interpreted clinically.

PSA levels may be influenced by prostate inflammation, urinary infection, recent ejaculation, certain prostate procedures or other factors. Our team will provide suitable preparation guidance before testing.

Our clinician will review the result alongside age, previous PSA values and individual risk factors. Repeat testing, further risk assessment, imaging or specialist urology evaluation may be recommended.

Screening frequency depends on age, initial PSA level, family history and individual risk. Our clinician will recommend an appropriate follow-up interval based on your results.

Cost depends on the consultation, PSA testing and any additional prostate assessment recommended. At Yoyime, the screening plan and associated costs are explained clearly beforehand.